Get the Stockscreener App
2.8901
1.41%
0.0401
Ac Immune Sa stock is traded at $2.8901, with a volume of 123.32K.
It is up +1.41% in the last 24 hours and down -12.42% over the past month.
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
See More
Previous Close:
$2.85
Open:
$2.81
24h Volume:
123.32K
Relative Volume:
0.43
Market Cap:
$290.74M
Revenue:
-
Net Income/Loss:
$-60.14M
P/E Ratio:
-4.0734
EPS:
-0.7095
Net Cash Flow:
$-68.17M
1W Performance:
-1.36%
1M Performance:
-12.42%
6M Performance:
+73.06%
1Y Performance:
-9.68%
1-Day Range:
$2.72
$2.90
1-Week Range:
$2.66
$3.04
52-Week Range:
$1.4299
$4.00
Ac Immune Sa Stock (ACIU) Company Profile
Compare ACIU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
2.8901 | 286.71M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-31-24 | Initiated | BTIG Research | Buy |
| Feb-01-19 | Downgrade | UBS | Buy → Neutral |
| Jan-04-19 | Initiated | UBS | Buy |
| Apr-05-18 | Initiated | H.C. Wainwright | Buy |
| Mar-23-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Oct-18-16 | Initiated | Credit Suisse | Outperform |
| Oct-18-16 | Initiated | Jefferies | Buy |
| Oct-18-16 | Initiated | Leerink Partners | Outperform |
View All
Ac Immune Sa Stock (ACIU) Latest News
Is AC Immune SA (IMR) stock a top dividend aristocrat candidate2025 Short Interest & Reliable Price Action Trade Plans - Newser
How AC Immune SA (IMR) stock reacts to weak economyJuly 2025 Action & Weekly Return Optimization Alerts - Newser
How big funds are accumulating AC Immune SA (IMR) stock2025 Market Sentiment & Free Reliable Trade Execution Plans - Newser
Will AC Immune SA (IMR) stock profit from AI boomCPI Data & Comprehensive Market Scan Insights - Newser
Why AC Immune SA (IMR) stock trades below fair valueQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
How geopolitical risks impact AC Immune SA (IMR) stock2025 Volume Leaders & Fast Entry Momentum Alerts - Newser
Will AC Immune SA (IMR) stock benefit from commodity supercycleWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser
What analysts say about AC Immune SA IMR stockShort Selling Opportunities & Free Explosive Wealth Accumulation - earlytimes.in
Adversity is less terrifying than hope: AC Immune SA (ACIU) - Setenews
Is AC Immune SA stock a top pick in earnings seasonQuarterly Trade Report & Expert Approved Momentum Ideas - newser.com
Why millennials buy AC Immune SA (IMR) stockJuly 2025 Catalysts & Fast Exit Strategy with Risk Control - newser.com
Will AC Immune SA stock recover faster than peersJuly 2025 Macro Moves & Community Supported Trade Ideas - newser.com
Is AC Immune SA (IMR) stock positioned for digital growth eraJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com
Why analysts remain bullish on AC Immune SA stockGDP Growth & Pattern Based Trade Signal System - newser.com
Can AC Immune SA stock resist sector downturnsEarnings Risk Summary & Expert Curated Trade Setup Alerts - newser.com
Signal strength of AC Immune SA stock in tech scannersBuy Signal & Momentum Based Trading Signals - newser.com
Why AC Immune SA stock remains on watchlistsWeekly Trade Recap & Free Community Consensus Stock Picks - newser.com
Will AC Immune SA (IMR) stock extend growth story2025 Growth vs Value & Smart Allocation Stock Reports - newser.com
What analyst consensus implies for AC Immune SA (IMR) stock2025 Technical Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
How to interpret RSI for AC Immune SA stockGap Down & Entry and Exit Point Strategies - newser.com
Can AC Immune SA stock sustain free cash flow growthWall Street Watch & Weekly Consistent Profit Watchlists - newser.com
Applying Wyckoff theory to AC Immune SA stock2025 Biggest Moves & Short-Term Trading Alerts - newser.com
Ac Immune Sa Stock (ACIU) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):